- Home
- MASK vs DYAI Comparison
MASK vs DYAI Comparison
Compare MASK & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASK
- DYAI
- Stock Information
- Founded
- MASK 2017
- DYAI 1979
- Country
- MASK Hong Kong
- DYAI United States
- Employees
- MASK N/A
- DYAI N/A
- Industry
- MASK
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MASK
- DYAI Health Care
- Exchange
- MASK NYSE
- DYAI Nasdaq
- Market Cap
- MASK 27.7M
- DYAI 28.3M
- IPO Year
- MASK 2025
- DYAI 2004
- Fundamental
- Price
- MASK $1.29
- DYAI $1.10
- Analyst Decision
- MASK
- DYAI Strong Buy
- Analyst Count
- MASK 0
- DYAI 1
- Target Price
- MASK N/A
- DYAI $6.00
- AVG Volume (30 Days)
- MASK 127.8K
- DYAI 186.3K
- Earning Date
- MASK 01-01-0001
- DYAI 08-12-2025
- Dividend Yield
- MASK N/A
- DYAI N/A
- EPS Growth
- MASK 12.16
- DYAI N/A
- EPS
- MASK 0.19
- DYAI N/A
- Revenue
- MASK $4,718,055.00
- DYAI $3,554,344.00
- Revenue This Year
- MASK N/A
- DYAI $22.56
- Revenue Next Year
- MASK N/A
- DYAI $30.95
- P/E Ratio
- MASK $6.52
- DYAI N/A
- Revenue Growth
- MASK 7.89
- DYAI 57.59
- 52 Week Low
- MASK $1.12
- DYAI $0.91
- 52 Week High
- MASK $4.19
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- MASK N/A
- DYAI 65.08
- Support Level
- MASK N/A
- DYAI $0.98
- Resistance Level
- MASK N/A
- DYAI $1.30
- Average True Range (ATR)
- MASK 0.00
- DYAI 0.08
- MACD
- MASK 0.00
- DYAI 0.02
- Stochastic Oscillator
- MASK 0.00
- DYAI 48.68
About MASK 3 E NETWORK TECHNOLOGY GROUP LTD
3 E Network Technology Group Ltd is a business-to-business (B2B) information technology (IT) business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.